Introduction Nitrosamines from Excipients primarily arise when trace levels of nitrite impurities present in inactive formulation components react with susceptible […]
Introduction Nitrosamine Control Strategy Development Services offer a comprehensive, science-driven framework for identifying, quantifying, and controlling mutagenic N-nitroso impurities throughout
Introduction The primary technical consideration when comparing NDSRIs with simple nitrosamines lies in understanding how differences in molecular complexity and
Introduction Nitrosamine Testing for Injectable Drug Products is a highly specialized analytical quality control procedure used to identify and quantify
Introduction: Nitrosamine testing for proton pump inhibitors has become a non-negotiable part of regulatory compliance for manufacturers of omeprazole, esomeprazole,
Introduction: Implementation of Nitrosamine Testing for Injectable Drug Products is a critical safety and regulatory requirement because parenteral drug products
Introduction A comprehensive peptide purity testing report must include validated chromatographic and mass spectrometric data to verify both chemical sequence
GC-MS vs LC-MS/MS for Nitrosamine Testing: How to Choose the Right Analytical Technique Read More »
Introduction: Nitrosamine control in continuous manufacturing is one of the most pressing quality and regulatory challenges facing pharmaceutical manufacturers today.
Introduction A formal nitrosamine risk assessment should begin during the preclinical stage of development, specifically during candidate selection and the
When Should You Start Nitrosamine Risk Assessment in Your Drug Development Program? Read More »
Introduction: Pharmacopoeial methods for nitrosamine testing were not purpose-built for the sensitivity levels modern regulators now demand. When the nitrosamine
